EURICAN PIRO
EURICAN PIRO
Not authorised
- Babesia canis canis, strain BC 14-9, soluble parasite antigen, Inactivated
Product identification
Medicine name:
EURICAN PIRO
Active substance:
- Babesia canis canis, strain BC 14-9, soluble parasite antigen, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Babesia canis canis, strain BC 14-9, soluble parasite antigen, Inactivated10.00/Indirect immunofluorescence unit(s)1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AO
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Espana S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Spanish Agency For Medicines And Health Products
Authorisation number:
- 3078 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 9/11/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 9/11/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
